CHESTER, N.J., Feb. 2 /PRNewswire-FirstCall/ -- Adams Respiratory Therapeutics, Inc. will provide a live audio webcast of a management presentation at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference in New York City on Feb. 9, 2006, at approximately 8:00 a.m. (ET). Michael J. Valentino, president and CEO, and David P. Becker, executive vice president, CFO and Treasurer, will review the company’s most recent business and financial results.
A live audio webcast of the presentation will be available by going to the Investor Relations section of the Adams web site, http://www.adamsrt.com, and clicking on the “News and Events” link. A replay of the webcast will be available later that day.
About Adams Respiratory Therapeutics, Inc.
Adams is a specialty pharmaceutical company focused on the late-stage development, commercialization and marketing of over-the-counter and prescription pharmaceuticals for the treatment of respiratory disorders.
Adams Respiratory Therapeutics, Inc.
CONTACT: Janet M. Barth, +1-908-879-2428 of Adams RespiratoryTherapeutics, Inc.
Web site: http://www.adamsrt.com/
